Cure My Disease

Don't miss your cure!

 Log in / Sign up

A phone app takes on the opioid crisis in high-risk workplaces

NCT ID NCT07799766

Prevention Sponsor: Prevention Strategies, LLC Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 02, 2026 · Last updated Sep 03, 2026 · Updated 1 time

Summary

Researchers are testing WorkWell, a mobile program designed to prevent prescription opioid misuse among construction workers and nurses. The app includes lessons on opioid risks, pain management alternatives, and how to talk with doctors. Participants answer questions about their beliefs and intentions before, right after, and about a month after using the program. The goal is to see whether these lessons can reduce the chance of opioid misuse and overuse in these high-risk jobs.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
WorkWell, a mobile-delivered behavioral intervention with lessons on opioid knowledge, pain management alternatives, and patient-provider communication
What this could lead to
If it works, WorkWell could give employers a practical tool to reduce prescription opioid misuse and overuse among workers in high-risk industries.
What could go wrong
This is an early-stage optimization trial, so the lessons may not change behavior in the long run. Results depend on self-reported outcomes, which can be unreliable.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

759 people

The number who actually took part.

Started

Aug 2024

Finished

Jan 2026

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Age 18 years or older Construction worker, nurse, or nursing assistant Exclusion Criteria: Under 18 years of age Not employed as a construction worker, nurse, or nursing assistant

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Opioids are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

opioid abuse prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Opioids

Contacts and locations

Locations

  • Cone Health

    Greensboro, North Carolina, 27401, United States

  • Samet Corporation

    Greensboro, North Carolina, 27409, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.